A possible role for π‐stacking in the self‐assembly of amyloid fibrils

Amyloid fibril formation is assumed to be the molecular basis for a variety of diseases of unrelated origin. Despite its fundamental clinical importance, the mechanism of amyloid formation is not fully understood. When we analyzed a variety of short functional fragments from unrelated amyloid‐forming proteins, a remarkable occurrence of aromatic residues was observed. The finding of aromatic residues in diverse fragments raises the possibility that IT‐IT interactions may play a significant role in the molecular recognition and self‐assembly processes that lead to amyloid formation. This is in line with the well‐known central role of π‐stacking interactions in self‐assembly processes in the fields of chemistry and biochemistry. We speculate that the stacking interactions may provide energetic contribution as well as order and directionality in the self‐assembly of amyloid structures. Experimental data regarding amyloid formation and inhibition by short peptide analogs also support our hypothesis. The π‐stacking hypothesis suggests a new approach to understanding the self‐assembly mechanism that governs amyloid formation and indicates possible ways to control this process.—Gazit, E. A possible role for π‐stacking in the self‐assembly of amyloid fibrils. FASEB J. 16, 77–83 (2002)

[1]  L. Tjernberg,et al.  Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.

[2]  S. Altschul.  Amino acid substitution matrices from an information theoretic perspective , 1991, Journal of Molecular Biology.

[3]  P. Westermark,et al.  Senile aortic amyloid. Evidence for two distinct forms of localized deposits. , 1992, The American journal of pathology.

[4]  P. Lansbury,et al.  The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? , 1995, Chemistry & biology.

[5]  J. Palha,et al.  4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid. , 2000, The American journal of pathology.

[6]  C. Dobson.  Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[7]  Claudio Soto,et al.  β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.

[8]  P E Fraser,et al.  Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. , 2001, Journal of molecular biology.

[9]  P E Fraser,et al.  Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid‐like fibrils , 2000, FEBS letters.

[10]  Ashok S. Shetty,et al.  Aromatic π-Stacking in Solution as Revealed through the Aggregation of Phenylacetylene Macrocycles , 1996 .

[11]  L. Tjernberg,et al.  Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Kemp,et al.  Controlling Polymerization of β-Amyloid and Prion-derived Peptides with Synthetic Small Molecule Ligands* , 2000, The Journal of Biological Chemistry.

[13]  N. Berger,et al.  Calcitonin-like immunoreactivity of amyloid fibrils in medullary thyroid carcinomas , 1988, Virchows Archiv A.

[14]  C. Hunter.  Arene—Arene Interactions: Electrostatic or Charge Transfer? , 1993 .

[15]  J. Fraser Stoddart,et al.  π–π INTERACTIONS IN SELF‐ASSEMBLY , 1997 .

[16]  E. Bernstein,et al.  Aromatic van der Waals Clusters: Structure and Nonrigidity , 1996 .

[17]  E. Ascari,et al.  Treatment of AL amyloidosis with 4'-lodo-4'-deoxydoxorubicin: an update. , 1999, Blood.

[18]  R. Leapman,et al.  Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. , 2000, Biochemistry.

[19]  Ehud Gazit,et al.  Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide , 2001, The Journal of Biological Chemistry.

[20]  B. Yankner,et al.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Sipe,et al.  Review: history of the amyloid fibril. , 2000, Journal of structural biology.

[22]  J. Bernhagen,et al.  Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.

[23]  J. Bernhagen,et al.  Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. , 2000, Journal of molecular biology.

[24]  G. Forloni,et al.  Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro. , 2000, Journal of molecular biology.

[25]  P. Lansbury,et al.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.

[26]  M. Tuite,et al.  Yeast Prions and Their Prion-Forming Domain , 2000, Cell.

[27]  C. Maury,et al.  Creation of amyloid fibrils from mutant Asn187 gelsolin peptides. , 1992, Biochemical and biophysical research communications.

[28]  J. Fraser Stoddart,et al.  Controlling Self‐Assembly , 1997 .

[29]  Ehud Gazit,et al.  The "Correctly Folded" state of proteins: is it a metastable state? , 2002, Angewandte Chemie.

[30]  Agueda Rostagno,et al.  A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.

[31]  F. Trimarchi,et al.  Homology of calcitonin with the amyloid-related proteins , 1994, Journal of endocrinological investigation.

[32]  S. Lindquist,et al.  Creating a protein-based element of inheritance. , 2000, Science.

[33]  B. Chesebro,et al.  Abnormal Properties of Prion Protein with Insertional Mutations in Different Cell Types* , 1998, The Journal of Biological Chemistry.

[34]  S. Kahn,et al.  Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. , 1999, Diabetes.

[35]  D. Allsop,et al.  A short synthesis of the β-amyloid (Aβ) aggregation inhibitor 3-p-Toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuran , 1999 .

[36]  C. Betsholtz,et al.  Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Raleigh,et al.  Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. , 1999, Journal of molecular biology.

[38]  G. McGaughey,et al.  pi-Stacking interactions. Alive and well in proteins. , 1998, The Journal of biological chemistry.

[39]  P. Westermark,et al.  The N-terminal segment of protein AA determines its fibrillogenic property. , 1992, Biochemical and biophysical research communications.

[40]  E. Sohar,et al.  In vitro synthesis of "amyloid"fibrils from insulin, calcitonin and parathormone. , 1976, Israel journal of medical sciences.

[41]  C. Blake,et al.  From the globular to the fibrous state: protein structure and structural conversion in amyloid formation , 1998, Quarterly Reviews of Biophysics.

[42]  M. Findeis,et al.  Modified-peptide inhibitors of amyloid beta-peptide polymerization. , 1999, Biochemistry.

[43]  Stephen J. DeArmond,et al.  Prion protein amyloid and neurodegeneration , 1995 .

[44]  Robert A. Grothe,et al.  An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[46]  E. Arbustini,et al.  Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J R Glover,et al.  Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast , 1996, Science.